Transdermal Composite Microneedle Composed of Mesoporous Iron Oxide Nanoraspberry and PVA for Androgenetic Alopecia Treatment
The transdermal delivery of therapeutic agents amplifying a local concentration of active molecules have received considerable attention in wide biomedical applications, especially in vaccine development and medical beauty. Unlike oral or subcutaneous injections, this approach can not only avoid the...
Main Authors: | Jen-Hung Fang, Che-Hau Liu, Ru-Siou Hsu, Yin-Yu Chen, Wen-Hsuan Chiang, Hui-Min David Wang, Shang-Hsiu Hu |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-06-01
|
Series: | Polymers |
Subjects: | |
Online Access: | https://www.mdpi.com/2073-4360/12/6/1392 |
Similar Items
-
Response to microneedling treatment in men with androgenetic alopecia who failed to respond to conventional therapy
by: Rachita Dhurat, et al.
Published: (2015-01-01) -
PHARMACOTHERAPY ALOPECIA ANDROGENETIC IN MEN
by: Riezky Januar Pramitha, et al.
Published: (2013-03-01) -
Platelet-rich plasma with microneedling in androgenetic alopecia: Study of efficacy of the treatment and the number of sessions required
by: Vani Yepuri, et al.
Published: (2021-01-01) -
Transdermal Delivery of Drugs with Microneedles—Potential and Challenges
by: Kevin Ita
Published: (2015-06-01) -
Microneedles: A smart approach and increasing potential for transdermal drug delivery system
by: Tejashree Waghule, et al.
Published: (2019-01-01)